IMN || Gastroenterology

IBD linked to increased risk of certain cancers

Posted on: 01/02/2014 - 05:01

Immunosuppressive therapies for inflammatory bowel disease do not appear to be implicated in the increased risk for melanomas and hematologic malignancies seen in these patients, based on the results...

Field of Interest: Gastroentero...

Type: News Item

New website provides guidance on treating hepatitis C, with regular updates

Posted on: 30/01/2014 - 16:35

A new website has been launched that provides the latest information to help guide clinicians on treating patients with chronic hepatitis C and will be updated regularly with developments in this...

Field of Interest: Gastroentero...

Type: News Item

Trial immunosuppressive therapy benefits outweigh long-term lymphoma risks in IBD

Posted on: 22/01/2014 - 18:40

HOLLYWOOD, FLA. – The benefits of short-term trial immunosuppressive therapy outweigh the risks in inflammatory bowel disease, but certain patient populations require more vigilance than others, Dr....

Field of Interest: Gastroentero...

Type: News Item

The price and cost of hepatitis C treatment

Posted on: 16/01/2014 - 19:55

Chronic hepatitis C virus (HCV) infection is a major cause of liver disease affecting 180 million people globally. HCV infection, both silent and slow in its revelation, and devastating in its...

Field of Interest: Gastroentero...

Type: News Item

Dual-vaccine therapy prolonged survival in pancreatic cancer

Posted on: 16/01/2014 - 18:35

SAN FRANCISCO – Serial administration of two vaccines that stimulate the immune response to pancreatic cancer antigens prolonged survival of metastatic disease by about 2 months, according to Dr....

Field of Interest: Gastroentero...

Type: News Item

Daclatasvir-sofosbuvir combo scores in resistant hepatitis C

Posted on: 15/01/2014 - 22:00

A combined regimen of daclatasvir and sofosbuvir achieved sustained virologic response rates greater than 90% in an industry-sponsored trial involving patients with chronic HCV, according to study...

Field of Interest: Gastroentero...

Type: News Item

Expanded genetic testing better predicts panitumumab plus chemo response

Posted on: 15/01/2014 - 19:50

SAN FRANCISCO – Patients with metastatic colorectal cancer should be broadly tested for RAS mutations before being treated with panitumumab, according to new data from a <link...

Field of Interest: Gastroentero...

Type: News Item

Metronidazole linked to increased risk for inflammatory bowel disease

Posted on: 02/01/2014 - 14:10

HOLLYWOOD, FLA. – Exposure to antibiotics other than penicillins, in particular metronidazole and quinolones, was associated with new-onset Crohn’s disease, based on a meta-analysis of observational...

Field of Interest: Gastroentero...

Type: News Item

Despite benefits, ‘bundling’ endoscopy is not norm

Posted on: 01/01/2014 - 05:01

In more than one-third of cases, same-day bidirectional endoscopy is not performed in Medicare beneficiaries, despite the fact that so-called "bundled" endoscopies offer significant cost...

Field of Interest: Gastroentero...

Type: News Item

Low-FODMAP diet reduced IBS symptoms

Posted on: 01/01/2014 - 05:01

Diets low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols reduced functional gastrointestinal symptoms in patients with irritable bowel syndrome. The finding, published...

Field of Interest: Gastroentero...

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters